Anhui Anke Biotechnology Hits Day High with Strong 4.76% Intraday Surge

Anhui Anke Biotechnology (Group) Co., Ltd. has experienced a notable increase of 4.76% on March 27, 2026, reaching an intraday high of CNY 9.27. This performance stands in contrast to the broader market, as the China Shanghai Composite index only rose by 0.63% on the same day. In terms of recent performance, Anhui Anke has shown a modest gain of 0.54% over the past week, while it has faced a decline of 7.68% over the last month. Year-to-date, the stock has decreased by 3.34%, which is slightly worse than the market's decline of 1.39%. Over the past year, the stock has generated a return of 4.17%, significantly lagging behind the China Shanghai Composite's return of 16.01%. Despite these fluctuations, Anhui Anke maintains a market capitalization of CNY 11,374 million and a price-to-earnings ratio of 25.00. The company also offers a dividend yield of 1.53%. However, it has faced challenges in long-term growth, with net sales and operating profit growth rates of 8.77% and 13.68%, respectively, over the last five years.